Showing results (2051-2060 of 3,086) with videos related to
Sort By:
Pageof 309
Drug Safety|June 20, 2014
Readability assessment of package inserts of biological medicinal products from the European medicines agency websiteMa Ángeles Piñero-López, Pilar Modamio, Cecilia F Lastra, et al.Drug Safety|June 22, 2014
Pharmacists in pharmacovigilance: can increased diagnostic opportunity in community settings translate to better vigilance?Paul Rutter, David Brown, Justine Howard, et al.Drug Safety|August 5, 2020
Ipilimumab-Induced Enterocolitis: A Systematic Review and Meta-AnalysisKelcie Witges, Leigh Anne Shafer, Ryan Zarychanski, et al.Drug Safety|July 4, 2020
Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the NetherlandsLinda Härmark, Gerda Weits, Rietje Meijer, et al.Drug Safety|April 11, 2023
Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future OpportunitiesVincent Bauchau, Kourtney Davis, Sarah Frise, et al.Drug Safety|April 6, 2023
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First DoseMonika Raethke, Florence van Hunsel, Nicolas H Thurin, et al.Drug Safety|April 12, 2023
Validation of an ICD-9-Based Algorithm to Identify Stillbirth Episodes from Medicaid Claims DataSabina O Nduaguba, Nicole E Smolinski, Thuy N Thai, et al.Drug Safety|May 1, 1991
Risk-benefit assessment of drugs used in the treatment of inflammatory bowel diseaseS B Hanauer, G StathopoulosDrug Safety|April 6, 2007
Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilanceMichael Perrio, Simon Voss, Saad A W ShakirDrug Safety|July 1, 1991
Acute cyclosporin overdose. A review of present clinical experienceF Arellano, C Monka, P F KruppPageof 309